Newcastle disease virus vaccine encapsulated in biodegradable nanoparticles for mucosal delivery of a human vaccine

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 8, 2014, Pages 2503-2506

  Sun, Yanwei ^a   Zhang, Yang ^a   Shi, Ci ^a   Li, Wei ^a   Chen, Gang ^a   Wang, Xiaohua ^a   Zhao, Kai ^a  

^a HEILONGJIANG UNIVERSITY   (China)

Author keywords

Chitosan; Mucosal immunity delivery system; Nanoparticles; Newcastle disease; Poly (D, L) lactic co glycolic acid

Indexed keywords

NANOPARTICLE; NEWCASTLE DISEASE VACCINE; BIODEGRADABLE PLASTIC; DRUG CARRIER; IMMUNOGLOBULIN G; VIRUS ANTIBODY; VIRUS VACCINE;

ANTIBODY RESPONSE; BIODEGRADATION; CLINICAL EFFECTIVENESS; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG RELEASE; DRUG RESPONSE; DRUG SAFETY; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFECTION PREVENTION; MUCOSAL DRUG DELIVERY SYSTEM; NANOENCAPSULATION; NEWCASTLE DISEASE; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; NOTE; OUTCOME ASSESSMENT; VIRUS IDENTIFICATION; ANIMAL; BLOOD; CHICKEN; IMMUNOLOGY; MUCOSAL DRUG ADMINISTRATION; NEWCASTLE DISEASE VIRUS; POULTRY DISEASES;

ADMINISTRATION, MUCOSAL; ANIMALS; ANTIBODIES, VIRAL; BIODEGRADABLE PLASTICS; CHICKENS; DRUG CARRIERS; IMMUNOGLOBULIN G; NANOPARTICLES; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; POULTRY DISEASES; VIRAL VACCINES;

EID: 84908370563     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.29201     Document Type: Note

References (23)

1. Bonifácio BV, Silva PB, Ramos MA, Negri KM, Bauab TM, Chorilli M. Nanotechnology-based drug delivery systems and herbal medicines: a review. Int J Nanomedicine 2014; 9:1-15; PMID:24363556
2. Gao B, Wang J, Wang D, Zhu Z, Qiao Z, Yang G, Nie F. A novel preparation method for drug nanocrystals and characterization by ultrasonic spray-assisted electrostatic adsorption. Int J Nanomedicine 2013; 8:3927-35; PMID:24143097; http://dx.doi.org/10.2147/IJN.S48597
3. de Moura MR, Aouada FA, Mattoso LH. Preparation of chitosan nanoparticles using methacrylic acid. J Colloid Interface Sci 2008; 321:477-83; PMID:18295778; http://dx.doi.org/10.1016/j.jcis.2008.02.006
4. Cui Z, Mumper RJ. Chitosan-based nanoparticles for topical genetic immunization. J Control Release 2001; 75:409-19; PMID:11489327; http://dx.doi.org/10.1016/S0168-3659(01)00407-2
5. Günbeyaz M, Faraji A, Ozkul A, Purali N, Senel S. Chitosan based delivery systems for mucosal immunization against bovine herpesvirus 1 (BHV-1). Eur J Pharm Sci 2010; 41:531-45; PMID:20800678; http://dx.doi.org/10.1016/j.ejps.2010.08.011
6. Gerdts V, Mutwiri G, Richards J, van Drunen Littelvan den Hurk S, Potter AA. Carrier molecules for use in veterinary vaccines. Vaccine 2013; 31:596-602; PMID:23219438; http://dx.doi.org/10.1016/j.vaccine.2012.11.067
7. Malhotra M, Lane C, Tomaro-Duchesneau C, Saha S, Prakash S. A novel method for synthesizing PEGylated chitosan nanoparticles: strategy, preparation, and in vitro analysis. Int J Nanomedicine 2011; 6:485-94; PMID:21562608
8. Arifin MA, Mel M, Abdul Karim MI, Ideris A. Production of Newcastle disease virus by Vero cells grown on cytodex 1 microcarriers in a 2-litre stirred tank bioreactor. J Biomed Biotechnol 2010; 2010:586363; PMID:20625497; http://dx.doi.org/10.1155/2010/586363
9. Tseng LP, Chiou CJ, Deng MC, Lin MH, Pan RN, Huang YY, Liu DZ. Evaluation of encapsulated Newcastle disease virus liposomes using various phospholipids administered to improve chicken humoral immunity. J Biomed Mater Res B Appl Biomater 2009; 91:621-5; PMID:19582853; http://dx.doi.org/10.1002/jbm.b.31437
10. Chimeno Zoth S, Gómez E, Carrillo E, Berinstein A. Locally produced mucosal IgG in chickens immunized with conventional vaccines for Newcastle disease virus. Braz J Med Biol Res 2008; 41:318-23; PMID:18392454; http://dx.doi.org/10.1590/S0100-879X2008000400010
11. Rauw F, Gardin Y, Palya V, Anbari S, Gonze M, Lemaire S, van den Berg T, Lambrecht B. The positive adjuvant effect of chitosan on antigen-specific cell-mediated immunity after chickens vaccination with live Newcastle disease vaccine. Vet Immunol Immunopathol 2010; 134:249-58; PMID:19939464; http://dx.doi.org/10.1016/j.vetimm.2009.10.028
12. Tretyakova I, Lukashevich IS, Glass P, Wang E, Weaver S, Pushko P. Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine. Vaccine 2013; 31:1019-25; PMID:23287629; http://dx.doi.org/10.1016/j.vaccine.2012.12.050
13. Zhao K, Li W, Huang T, Luo X, Chen G, Zhang Y, Guo C, Dai C, Jin Z, Zhao Y, et al. Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in PLGA nanoparticles. PLoS One 2013; 8:e82648; PMID:24386106; http://dx.doi.org/10.1371/journal.pone.0082648
14. Zhao K, Chen G, Shi XM, Gao TT, Li W, Zhao Y, Zhang FQ, Wu J, Cui X, Wang YF. Preparation and efficacy of a live newcastle disease virus vaccine encapsulated in chitosan nanoparticles. PLoS One 2012; 7:e53314; PMID:23285276; http://dx.doi.org/10.1371/journal.pone.0053314
15. Tseng LP, Liang HJ, Deng MC, Lee KM, Pan RN, Yang JC, Huang YY, Liu DZ. The influence of liposomal adjuvant on intranasal vaccination of chickens against Newcastle disease. Vet J 2010; 185:204-10; PMID:19570697; http://dx.doi.org/10.1016/j.tvjl.2009.05.019
16. Zhao K, Shi X, Zhao Y, Wei H, Sun Q, Huang T, Zhang X, Wang Y. Preparation and immunological effectiveness of a swine influenza DNA vaccine encapsulated in chitosan nanoparticles. Vaccine 2011; 29:8549-56; PMID:21945253; http://dx.doi.org/10.1016/j.vaccine.2011.09.029
17. Abbas AO, Donovan MD, Salem AK. Formulating poly(lactide-co-glycolide) particles for plasmid DNA delivery. J Pharm Sci 2008; 97:2448-61; PMID:17918737; http://dx.doi.org/10.1002/jps.21215
18. Loke CF, Omar AR, Raha AR, Yusoff K. Improved protection from velogenic Newcastle disease virus challenge following multiple immunizations with plasmid DNA encoding for F and HN genes. Vet Immunol Immunopathol 2005; 106:259-67; PMID:15963824; http://dx.doi.org/10.1016/j.vetimm.2005.03.005
19. Slütter B, Plapied L, Fievez V, Sande MA, des Rieux A, Schneider YJ, Van Riet E, Jiskoot W, Préat V. Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination. J Control Release 2009; 138:113-21; PMID:19445980; http://dx.doi.org/10.1016/j.jconrel.2009.05.011
20. Ugwoke MI, Agu RU, Verbeke N, Kinget R. Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives. Adv Drug Deliv Rev 2005; 57:1640-65; PMID:16182408; http://dx.doi.org/10.1016/j.addr.2005.07.009
21. Zhao K, Zhang Y, Zhang X, Li W, Shi C, Guo C, Dai C, Chen Q, Jin Z, Zhao Y, et al. Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in chitosan nanoparticles. Int J Nanomedicine 2014; 9:389-402; PMID:24426783; http://dx.doi.org/10.2147/IJN.S54226
22. Basarkar A, Devineni D, Palaniappan R, Singh J. Preparation, characterization, cytotoxicity and transfection efficiency of poly(DL-lactideco-glycolide) and poly(DL-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA. Int J Pharm 2007; 343:247-54; PMID:17611054; http://dx.doi.org/10.1016/j.ijpharm.2007.05.023
23. Liu SW, Chen HY, Cao DJ, Lu JL. Effect on chicken lymphocytes by Newcastle disease virus. Chin J Animal Poult Infect Dis 1998; 20:140-2